Predictive and prognostic roles ofBRAFmutation in patients with metastatic colorectal cancer treated with anti-epidermal growth factor receptor monoclonal antibodies: A meta-analysis

Monoclonal Antibodies ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Meta Analysis ◽

Growth Factor Receptor ◽

Promising biomarkers for predicting the outcomes of patients withKRASwild-type metastatic colorectal cancer treated with anti-epidermal growth factor receptor monoclonal antibodies: A systematic review with meta-analysis

International Journal of Cancer ◽

10.1002/ijc.28153 ◽

2013 ◽

Vol 133 (8) ◽

pp. 1914-1925 ◽

Cited By ~ 51

Author(s):

Zu-Yao Yang ◽

Xin-Yin Wu ◽

Ya-Fang Huang ◽

Meng-Yang Di ◽

Da-Yong Zheng ◽

...

Keyword(s):

Colorectal Cancer ◽

Systematic Review ◽

Monoclonal Antibodies ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Meta Analysis ◽

Growth Factor Receptor ◽

Anti-epidermal growth factor receptor monoclonal antibodies in metastatic colorectal cancer: A meta-analysis

World Journal of Gastroenterology ◽

10.3748/wjg.v21.i14.4365 ◽

2015 ◽

Vol 21 (14) ◽

pp. 4365 ◽

Cited By ~ 2

Author(s):

Qi-Bin Song

Keyword(s):

Colorectal Cancer ◽

Monoclonal Antibodies ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Meta Analysis ◽

Growth Factor Receptor ◽

PD-013 A study level meta-analysis of efficacy data from head-to-head first-line trials of epidermal growth factor receptor inhibitors (EGFRIs) vs bevacizumab in patients with metastatic colorectal cancer (mCRC)

Annals of Oncology ◽

10.1093/annonc/mdv234.12 ◽

2015 ◽

Vol 26 ◽

pp. iv104

Author(s):

V. Heinemann ◽

F. Rivera ◽

B. O'Neill ◽

R. Koukakis ◽

J.H. Terwey ◽

...

Keyword(s):

Colorectal Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Meta Analysis ◽

Growth Factor Receptor ◽

First Line ◽

Efficacy Data ◽

Integrated molecular dissection of the epidermal growth factor receptor (EFGR) oncogenic pathway to predict response to EGFR-targeted monoclonal antibodies in metastatic colorectal cancer

Targeted Oncology ◽

10.1007/s11523-010-0138-5 ◽

2010 ◽

Vol 5 (1) ◽

pp. 19-28 ◽

Cited By ~ 23

Author(s):

Andrea Sartore-Bianchi ◽

Katia Bencardino ◽

Federica Di Nicolantonio ◽

Federico Pozzi ◽

Chiara Funaioli ◽

...

Keyword(s):

Colorectal Cancer ◽

Monoclonal Antibodies ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Molecular Dissection ◽

Oncogenic Pathway ◽

Erratum to: Integrated molecular dissection of the epidermal growth factor receptor (EGFR) oncogenic pathway to predict response to EGFR-targeted monoclonal antibodies in metastatic colorectal cancer

Targeted Oncology ◽

10.1007/s11523-010-0142-9 ◽

2010 ◽

Vol 7 (4) ◽

pp. 267-267

Author(s):

Andrea Sartore-Bianchi ◽

Katia Bencardino ◽

Federica Di Nicolantonio ◽

Federico Pozzi ◽

Chiara Funaioli ◽

...

Keyword(s):

Colorectal Cancer ◽

Monoclonal Antibodies ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Molecular Dissection ◽

Oncogenic Pathway ◽

Clinical Use of Anti–Epidermal Growth Factor Receptor Monoclonal Antibodies in Metastatic Colorectal Cancer

Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ◽

10.1592/phco.28.11-supp.31s ◽

2008 ◽

Vol 28 (11 Part 2) ◽

pp. 31S-41S ◽

Cited By ~ 21

Author(s):

Dina K Patel

Keyword(s):

Colorectal Cancer ◽

Monoclonal Antibodies ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Clinical Use ◽

Efficacy of bevacizumab versus epidermal growth factor receptor inhibitors for wild-type RAS metastatic colorectal cancer: a meta-analysis

OncoTargets and Therapy ◽

10.2147/ott.s168695 ◽

2018 ◽

Vol Volume 11 ◽

pp. 4271-4281

Author(s):

Wei Jiang ◽

Qitao Yu ◽

Ruiling Ning ◽

Wenhua Zhao ◽

Changyuan Wei

Keyword(s):

Colorectal Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Meta Analysis ◽

Growth Factor Receptor ◽

Wild Type ◽

Meta-analysis: The efficacy and safety of monoclonal antibody targeted to epidermal growth factor receptor in the treatment of patients with metastatic colorectal cancer

Journal of Digestive Diseases ◽

10.1111/j.1751-2980.2009.00393.x ◽

2009 ◽

Vol 10 (4) ◽

pp. 247-257 ◽

Cited By ~ 12

Author(s):

Fang NIE ◽

Jun SHEN ◽

Jin Lu TONG ◽

Xi Tao XU ◽

Ming Ming ZHU ◽

...

Keyword(s):

Colorectal Cancer ◽

Monoclonal Antibody ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Meta Analysis ◽

Growth Factor Receptor ◽

Efficacy And Safety ◽

Location of Primary Tumor and Benefit From Anti‐Epidermal Growth Factor Receptor Monoclonal Antibodies in Patients With RAS and BRAF Wild‐Type Metastatic Colorectal Cancer

The Oncologist ◽

10.1634/theoncologist.2016-0084 ◽

2016 ◽

Vol 21 (8) ◽

pp. 988-994 ◽

Cited By ~ 42

Author(s):

Roberto Moretto ◽

Chiara Cremolini ◽

Daniele Rossini ◽

Filippo Pietrantonio ◽

Francesca Battaglin ◽

...

Keyword(s):

Colorectal Cancer ◽

Monoclonal Antibodies ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Primary Tumor ◽

Growth Factor Receptor ◽

Wild Type ◽

Epidermal Growth Factor Receptor Monoclonal Antibodies for the Treatment of Metastatic Colorectal Cancer

Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ◽

10.1592/phco.28.6.742 ◽

2008 ◽

Vol 28 (6) ◽

pp. 742-754 ◽

Cited By ~ 56

Author(s):

Gary W Jean ◽

Sachin R Shah

Keyword(s):

Colorectal Cancer ◽

Monoclonal Antibodies ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽